285 related articles for article (PubMed ID: 18211942)
21. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Tao Y; Hou J; Jiang YR; Li XX; Jonas JB
Eye (Lond); 2010 May; 24(5):810-5. PubMed ID: 19696805
[TBL] [Abstract][Full Text] [Related]
22. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
[TBL] [Abstract][Full Text] [Related]
23. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
24. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis.
Guthoff R; Meigen T; Hennemann K; Schrader W
Ophthalmologica; 2010; 224(5):319-24. PubMed ID: 20424494
[TBL] [Abstract][Full Text] [Related]
25. Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion.
Yasuda S; Kondo M; Kachi S; Ito Y; Terui T; Ueno S; Terasaki H
Retina; 2011 Jun; 31(6):1075-82. PubMed ID: 21478810
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
Ehlers JP; Decroos FC; Fekrat S
Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
[TBL] [Abstract][Full Text] [Related]
27. A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1.
Narayanan R; Panchal B; Das T; Chhablani J; Jalali S; Ali MH;
Br J Ophthalmol; 2015 Jul; 99(7):954-9. PubMed ID: 25631483
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion.
Risard SM; Pieramici DJ; Rabena MD; Basefsky JC; Avery RL; Castellarin AA; Nasir MA; See RF; Couvillion SS
Retina; 2011 Jun; 31(6):1060-7. PubMed ID: 21283055
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study.
Hou J; Tao Y; Jiang YR; Li XX; Gao L
Chin Med J (Engl); 2009 Nov; 122(22):2695-9. PubMed ID: 19951598
[TBL] [Abstract][Full Text] [Related]
30. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.
Campochiaro PA; Heier JS; Feiner L; Gray S; Saroj N; Rundle AC; Murahashi WY; Rubio RG;
Ophthalmology; 2010 Jun; 117(6):1102-1112.e1. PubMed ID: 20398941
[TBL] [Abstract][Full Text] [Related]
31. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
32. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
[TBL] [Abstract][Full Text] [Related]
33. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab.
Nagaoka T; Sogawa K; Yoshida A
Retina; 2014 Oct; 34(10):2037-43. PubMed ID: 24896136
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
Kim M; Jeong S; Sagong M
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
[TBL] [Abstract][Full Text] [Related]
35. [Short-term effects of intravitreal injection of bevacizumab on macular edema due to central retinal vein occlusion].
Hayashi A; Ueta Y; Yunoki T; Mitarai K; Miyakoshi A; Takeda S; Fujita K; Watanabe K; Yanagisawa S; Kitagawa K
Nippon Ganka Gakkai Zasshi; 2010 Apr; 114(4):347-55. PubMed ID: 20432959
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
Salinas-Alamán A; Zarranz-Ventura J; Caire González-Jauregui JM; Sádaba-Echarri LM; Barrio-Barrio J; García-Layana A
Eur J Ophthalmol; 2011; 21(4):434-9. PubMed ID: 21140369
[TBL] [Abstract][Full Text] [Related]
38. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.
Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C
Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497
[TBL] [Abstract][Full Text] [Related]
39. Bevacizumab intravitreal injections in the treatment of diabetic macular oedema.
Małgorzata W; Diana D; Agnieszka B; Zofia M
Klin Oczna; 2013; 115(1):15-9. PubMed ID: 23882733
[TBL] [Abstract][Full Text] [Related]
40. Short term results of intra-vitreal bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
Thapa R; Poudyal G
Nepal J Ophthalmol; 2013; 5(1):63-8. PubMed ID: 23584649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
